Covaxin can be taken off 'clinical trial mode', expert panel recommends

In clinical trial mode, people needed to sign a consent form to take Covaxin, one of the two vaccines allowed for use in India, the other being Oxford-AstraZeneca's Covishield, developed by the Serum Institute of India

TBS Report

10 March, 2021, 07:40 pm

Last modified: 10 March, 2021, 08:05 pm

Covaxin can be taken off 'clinical trial mode', expert panel recommends

Bharat Biotech's Covid-19 vaccine Covaxin can be taken off clinical trial mode, a subject expert committee that has been monitoring the vaccine development has recommended to India's drugs regulator DCGI.

If Covaxin is no longer administered under clinical trial mode, people don't have to sign a consent form to take the vaccine, reports the NDTV.

The subject expert committee recommended Covaxin to be given emergency use authorisation after going through the Indian vaccine's phase 3 trial data.

Keep updated, follow The Business Standard's Google news channel

In clinical trial mode, people needed to sign a consent form to take Covaxin, one of the two vaccines allowed for use in India, the other being Oxford-AstraZeneca's Covishield, developed by the Serum Institute of India.

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.